What top creators are saying about Ovid Therapeutics Inc.(OVID)
Biopharmaceutical company with an upcoming catalyst for drug OV329
3 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Ovid Therapeutics Inc. in the last 30 days yet.
Top creators covering Ovid Therapeutics Inc. (OVID)
The 2 sources with the most insights about Ovid Therapeutics Inc. on Kazuha.
Latest insights about Ovid Therapeutics Inc. (OVID)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Saturday, October 3, 2026
Sentiment was mixed: one investor was bullish, while another cited weak historical share performance and concerns about former leadership; a leadership succession announcement was floated as a possible explanation for a recent rise.
Wednesday, September 30, 2026
The speaker criticized the company's past performance and leadership history and was dismissive, but did not provide a detailed assessment of its current pipeline or finances.
Monday, September 29, 2025
Viewed as a 'crappy drug company' with an upcoming binary event for its drug OV329 that is expected to yield meaningless data, leading to a very low confidence outlook.
Saturday, October 3, 2026
Sentiment was mixed: one investor was bullish, while another cited weak historical share performance and concerns about former leadership; a leadership succession announcement was floated as a possible explanation for a recent rise.
Wednesday, September 30, 2026
The speaker criticized the company's past performance and leadership history and was dismissive, but did not provide a detailed assessment of its current pipeline or finances.
Monday, September 29, 2025
Viewed as a 'crappy drug company' with an upcoming binary event for its drug OV329 that is expected to yield meaningless data, leading to a very low confidence outlook.
Discussed alongside Ovid Therapeutics Inc. (OVID)
Other assets that creators frequently mention in the same content as Ovid Therapeutics Inc..
Frequently asked
Which podcasters and creators cover Ovid Therapeutics Inc. (OVID) the most?
The most active sources covering Ovid Therapeutics Inc. (OVID) on Kazuha are @realmartinshkreli, @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Ovid Therapeutics Inc. (OVID) are on Kazuha?
Kazuha has indexed 3 AI-extracted insights about Ovid Therapeutics Inc. (OVID) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Ovid Therapeutics Inc. (OVID)?
Creators covering Ovid Therapeutics Inc. (OVID) most frequently also discuss LXEO, MU, AMD, INTC, NKTR. See the "Discussed alongside" section above for full asset pages.